FDA Expected To Authorize COVID-19 Booster Shots

WASHINGTON – The Food and Drug Administration is expected to approve COVID-19 booster shots for immunocompromised people sometime Thursday.

That’s according to a source who is familiar with the ongoing talks.

This will end up being a third shot for the Pfizer and Moderna vaccines which are two-doses each.

The FDA has not officially commented on the issue.

This comes as health officials keep stressing the importance of getting vaccinated against COVID-19.

The Centers for Disease Control and Prevention reports more than 98-percent of Americans live in areas that are considered to have a “high” or “substantial” risk of community transmission of the potentially-deadly virus.